Association of Placental Fetal and Maternal Vascular Malperfusion With Bronchopulmonary Dysplasia and Mortality in Preterm Infants
The European Research Journal · 2026-11-01 · 1270-1276
DOI: 10.18621/eurj.1250 ↗Abstract
Objective: To investigate the association of placental histopathological abnormalities with bronchopulmonary dysplasia (BPD) and mortality in preterm infants. Methods: This prospective study included preterm infants (gestational age ≤32 weeks; birth weight ≤1500 g) followed up in the neonatal intensive care unit of a tertiary university hospital between May 2019 and May 2020. Preterm infants were divided into Group 1 (with BPD; n = 12) and Group 2 (without BPD; n = 23). Placentas were evaluated using the Amsterdam Placental Workshop Group Consensus Statement. Results: Thirty-five preterm infants were evaluated. The mean (SD) birth weight was statistically significantly lower in Group 1 (1045.25 [160.63] g) than in Group 2 (1453.95 [529.08] g) (P = .002). Group 1 (median [minimum-maximum] gestational age, 27.50 [26-29] weeks) was statistically significantly younger than Group 2 (30.50 [25-32] weeks) (P < .001). Nosocomial sepsis occurred at a significantly higher rate in Group 1 (58.3% [n = 7]) than in Group 2 (13.0% [n = 3]) (P = .02). The median length of hospital stay (51 [38-92] vs 21 [1-74] days; P < .001) and median days of noninvasive ventilation (11 [2-57] vs 2 [0-43] days; P < .001) were significantly greater in Group 1 than in Group 2. Maternal and fetal vascular malperfusion lesions were the most frequent findings and were higher in Group 2. Mortality occurred exclusively in Group 2 (21.7% [n = 5] vs 0.0% [n = 0]). Conclusions: No statistically significant differences were observed in placental histopathological findings between the groups, with maternal and fetal vascular malperfusion representing the most frequent lesions. Mortality was seen exclusively in the non-BPD group. These findings suggest an association between placental vascular pathologies and neonatal mortality; however, larger-scale, multicenter studies are warranted.
EUVIMED